These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11242638)

  • 21. [Statistical review of biliary tract cancer].
    Koyama K; Kikuchi T; Tanaka J
    Nihon Rinsho; 1993 Jan; 51 Suppl():735-45. PubMed ID: 8459609
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cancer of the bile ducts in Denmark, 1943-1982].
    Mellemgaard A
    Ugeskr Laeger; 1987 Dec; 149(50):3423-6. PubMed ID: 3433549
    [No Abstract]   [Full Text] [Related]  

  • 23. Mortality from hepatocellular and biliary cancers: changing epidemiological trends.
    Nair S; Shiv Kumar K; Thuluvath PJ
    Am J Gastroenterol; 2002 Jan; 97(1):167-71. PubMed ID: 11808943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whether or not prophylactic excision of the extrahepatic bile duct is appropriate for patients with pancreaticobiliary maljunction without bile duct dilatation.
    Kusano T; Takao T; Tachibana K; Tanaka Y; Kamachi M; Ikematsu Y; Nishiwaki Y; Kida H; Waki S; Uchimura M; Furukawa M
    Hepatogastroenterology; 2005; 52(66):1649-53. PubMed ID: 16334749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Trends & current status in cancer of the biliary tract].
    Yoshimi I; Sobue T
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():322-30. PubMed ID: 16457275
    [No Abstract]   [Full Text] [Related]  

  • 26. Status of surgical treatment of biliary tract cancer.
    Ishihara S; Miyakawa S; Takada T; Takasaki K; Nimura Y; Tanaka M; Miyazaki M; Nagakawa T; Kayahara M; Horiguchi A
    Dig Surg; 2007; 24(2):131-6. PubMed ID: 17446708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients.
    Kayahara M; Nagakawa T
    Cancer; 2007 Aug; 110(3):572-80. PubMed ID: 17594719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.
    Nagakawa T; Kayahara M; Ikeda S; Futakawa S; Kakita A; Kawarada H; Matsuno M; Takada T; Takasaki K; Tanimura H; Tashiro S; Yamaoka Y
    J Hepatobiliary Pancreat Surg; 2002; 9(5):569-75. PubMed ID: 12541042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
    Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
    Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diet and biliary tract cancer risk in Shanghai, China.
    Nelson SM; Gao YT; Nogueira LM; Shen MC; Wang B; Rashid A; Hsing AW; Koshiol J
    PLoS One; 2017; 12(3):e0173935. PubMed ID: 28288186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary tract cancer mortality rates by prefectures in Japan.
    Yamamoto S
    Jpn J Clin Oncol; 2000 Dec; 30(12):576. PubMed ID: 11210170
    [No Abstract]   [Full Text] [Related]  

  • 32. Worldwide trends in mortality from biliary tract malignancies.
    Patel T
    BMC Cancer; 2002 May; 2():10. PubMed ID: 11991810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
    Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
    Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biliary tract cancer].
    Asanuma Y; Andoh H; Tanaka J; Koyama K
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():301-6. PubMed ID: 11808135
    [No Abstract]   [Full Text] [Related]  

  • 35. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study.
    Ahrens W; Timmer A; Vyberg M; Fletcher T; Guénel P; Merler E; Merletti F; Morales M; Olsson H; Olsen J; Hardell L; Kaerlev L; Raverdy N; Lynge E
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):623-30. PubMed ID: 17625430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Laparoscopic cholecystectomy--accessory bile ducts].
    Balija M; Huis M; Szerda F; Bubnjar J; Stulhofer M
    Acta Med Croatica; 2003; 57(2):105-9. PubMed ID: 12879689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of future cancer mortality in Japan.
    Kuroishi T; Hirose K; Tominaga S; Ogawa H; Tajima K
    Jpn J Clin Oncol; 1992 Oct; 22(5):365-9. PubMed ID: 1469799
    [No Abstract]   [Full Text] [Related]  

  • 40. Geographic clustering patterns in mortality from biliary tract cancer in Japan.
    Kodama K; Nakadaira H; Endoh K; Yamamoto M
    Jpn J Cancer Res; 1998 Jan; 89(1):6-11. PubMed ID: 9510468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.